- Methodology article
- Open Access
Comparative study of the effects of fetal bovine serum versus horse serum on growth and differentiation of primary equine bronchial fibroblasts
© Franke et al.; licensee BioMed Central Ltd. 2014
Received: 31 August 2013
Accepted: 20 May 2014
Published: 26 May 2014
Airway fibroblasts have become a critical addition to all facets of structural lung tissue changes such as in human asthma and chronic obstructive pulmonary disease, but little is known about their role in the equine recurrent airway obstruction, a disease that resembles to the human asthma. Since the equine bronchial fibroblasts (EBF) have not been isolated and characterized yet, the use of defined medium was investigated.
Primary EBF were cultured on non-collagen coated flasks without serum or in the presence of fetal bovine serum (FBS) or horse serum (HS) or in serum depleted medium. EBF cultured in serum-free basal media and those serum deprived were not able to proliferate and even exhibited considerable cell death. In media containing FBS or HS, proliferation of the cells was reproducible between different primary cultures and cells demonstrated expression of vimentin. Large variations were found in the ability of FBS and HS to support growth and differentiation of EBF in monolayer culture. Indications of growth-promoting actions, increasing passage number as well as maintaining fibroblast morphology were found rather in FBS than in HS. EBF culturing in HS needed longer doubling and confluence time. The protein content of the cell pellets was higher in EBF cultured in medium containing HS than FBS. Alpha-smooth muscle actin seemed to be less expressed in EBF cultured in medium containing FBS than those in HS.
In sum, serum addition to basal EBF medium enhanced EBF differentiation into myofibroblasts, and these findings are useful to develop in vitro fibroblast culture models that mimic in vivo physiological processes and to study airway disease mechanisms and remodeling.
Chronic airway diseases like human bronchial asthma and chronic obstructive pulmonary disease (COPD) and the equine recurrent airway obstruction (RAO) principally characterized by bronchial hyperreactivity and airflow obstruction result from several factors including structural alterations of the airway wall and cell function. Such airway remodelling is a common feature of abnormal deposition of extracellular matrix (ECM) components in airway mesenchymal layer associated with airway wall thickness [1–3]. Airway fibroblasts and those cells differentiated into myofibroblasts contribute to sub-epithelial fibrosis linked to airway remodelling by producing ECM proteins such as collagen, fibronectin and proteoglycans [4, 5].
There are several well characterized human fetal lung fibroblast cell lines that are cultured in defined media and for use as in vitro cell model to study airway diseases and remodeling, for example, HFL-1 , IMR-90 , HEL299, MCR-5 , WI-38  and GM 06114 . Culture of primary bronchial fibroblasts exists for human [11, 12], mice  and rats . However, there is currently neither description of equine adult primary airway fibroblast cultures nor there are such cell lines for this species.
Not all cells have the same requirements for growth and survival. With this regard, for successful growth, maintenance and expression of differentiated metabolic functions of human or animal cells in vitro, either primary cultures or continuous cell lines, appropriate culture conditions are required that mimic the physiological conditions in vivo and situ. In fact, it is well known that serum represents a fundamental source of nutrients, cytokines and adhesive molecules necessary for in vitro cell growth, metabolism and to stimulate proliferation . In serum-free medium, only the addition of growth factors could initiate mouse lung fibroblast proliferation . On the other hand, proliferating primary cardiac and dermal fibroblasts as well as established cell lines have been synchronized into a non-dividing G0-phase to cell cycle by serum withdrawal  which favour fibrotic processes or cause cell death [18, 19]. While significant advances are made to culture conditions of permanent cell lines, current research is lacking that compares cultures of primary airway fibroblasts in different serum origins added to a standard culture medium or serum depleted medium, and how this may affect their differentiation. The sera that most widely used are bovine origin (adult or new born or fetal origin); as well the horse serum has been seen as an alternative to provide growth factors and hormones in modern cell biology. Indeed, almost it is not known about the responses of primary airway fibroblast cultures to horse serum factors.
Aim of the present study was to develop a primary bronchial fibroblast culture technique and investigate the influence of horse serum in comparison to FBS on cell viability, morphology and immunocytochemical characteristics, cell proliferation and α-smooth muscle actin expression (α-sma) to further understand the mechanism of peribronchial fibrosis (airway remodelling) in the equine RAO.
Effect of serum absence and serum withdrawal on primary EBF culture
Primary EBF cultured without serum presence in basic DMEM failed to attach and to proliferate and those attached, disappeared completely from the flask surfaces within 1-week of culture. Also, we tested whether confluent EBF cultured in DMEM can be affected by serum withdrawal. Serum withdrawal led to modification of EBF number in culture; they exhibited detachment within three days of serum starvation (data not shown). Even the addition of 10% FBS after 24 h did not significantly enhance EBF attachment and proliferation.
Cell viability and morphology under FBS and HS influence
Sera effects on cell population, proliferation and total protein
α-Smooth muscle actin expression
The overall aim of the present investigation was to assess viability, morphological and proliferation differences of primary bronchial fibroblasts of the horse subjected to basal medium without serum, or first serum containing but later serum-depleted medium, in the presence of fetal bovine serum or horse serum. The results highlight differences in examined parameters when primary EBF were cultured within these differing conditions. In the absence of serum, basal medium DMEM did not support EBF attachment and proliferation; serum withdrawal in sub-confluent EBF has also led to decreased cell proliferation and attachment. The most important factors in significantly affecting cell growth and differentiation were the sera types added to basal DMEM. EBF cultures were established from freshly isolated EBF (P0) or from frozen isolated EBF. Despite cryopreservation, the proliferation data generated from frozen cells were similar to those from freshly solated and further cultured EBF.
After short-term trypsin digestion of peeled and minced equine bronchial mucosa and from cultures of epithelial cell mixture in DMEM containing FBS, we could observe a complete disappearance of epithelial cells within 1-week and instead five days later a complete coverage of culture flasks with viable primary equine bronchial fibroblasts. Thus, DMEM does not support epithelial cell growth despite the presence of serum. This isolation procedure is described, to our knowledge, the first time for these cells and resulted in reproducible large cell yields with typical mesenchymal cell properties. EBF cultured in serum-free DMEM were, however, not only unable to proliferate but also were non-adherent after seven days in culture. From this result, indeed, it is difficult to point out the proteins which are present in serum and absent in the basal medium that are essential for primary EBF growth. The reason why EBF disappeared seems to be, even if we did not proof, the occurrence of apoptosis and necrosis. Thus, it can be argued that under serum-free conditions in our cultures EBF-specific growth factors which are usually present in serum are missing. But in many established permanent cell line culture under serum-free conditions [20, 21] the serum-free environment did support growth and differentiation with clonal growth as well as mass culture (for review see ).
Although recent efforts have shown that human mesenchymal stem cells and primary epithelial cells can be isolated and expanded long-term in serum-free medium [23–26], no published work had shown whether human or animal primary airway fibroblasts are able to expand under serum-free conditions for long-term in culture. The selective nature of serum-free media formulations could be used in primary cultures of tissue explants by allowing growth suppression of other cell types which might quantitatively influence experiments with primary cells obtained from tumor tissues. Presumably, in our case, the serum-free condition should be optimized for enhanced primary fibroblast expansion by adding growth factors which have to be further investigated. In sum, understanding of these processes is essential in understanding the use of these cells as in vitro model and to study their role in airway remodelling during respiratory disease mechanisms.
The importance of serum supplementation for cell attachment, growth and passaging of in vitro proliferating cells  as well as the influence of serum deprivation on permanent cell line proliferation and cycle  are well known. On the other hand, no data are available on the effect of time–dependent serum withdrawal on primary airway fibroblast proliferation and differentiation. Since serum components might affect cell stimulation, many studies in vitro are conducted in the absence of serum, and cells can be deprived of serum for 1 – 8 days [29, 30], and thus, the aim of the present study was to investigate the response to serum withdrawal for 24 to 48 hours in sub-confluent primary equine bronchial fibroblasts which were first cultured in DMEM containing 10% FBS. In our study, we have clearly demonstrated a marked time-dependent decrease in [3H]-thymidine incorporation in cells deprived of serum for 24 to 48 hours, suggesting discontinuation of proliferation in the absence of FBS. After 72 hours of serum depletion many cells were floating in the medium and the number of attached cells was decreasing, indicating altering cell viability and morphology, in agreement with data found for cardiac fibroblasts . These findings show that EBF in primary cultures are not able to adapt to serum deprivation for a given time, presumably sufficient serum growth factors are not available.
Moreover, we have tested the effects of sera types on proliferation, morphology, population doubling and viability of primary equine bronchial fibroblasts. The results highlight striking differences in cell proliferation, morphology, passaging time and number as well as total protein amount and α-SMA expression when EBF were cultured within these differing conditions. Both FBS and HS are natural products, presumably, with varying concentrations of growth factors within different batches; however, the effects measured in our study were not dependent on batch/lot number. EBF grown in DMEM containing 10% FBS continue to proliferate even after reaching confluence, whereas these same cells, when cultured in DMEM containing 10% HS, had relatively limited proliferation rate, longer population doubling time and somehow quite different morphological features. Cells in HS were smaller, chain-forming and more compact in shape with dark cytoplasmic granules which can be related to the occurrence of abnormal protein accumulation than those in FBS, and they failed to reach confluence. In concordance, sera types affect other various cell types in a similar way: bovine adipocytes and sheep skeletal muscle satellite cells proliferated rapidly, when FBS was supplemented to growth medium instead of HS; thus, FBS-containing medium is often used as growth medium in these cultures [31, 32]. On the contrary, equine chondrocytes could equally proliferate under both conditions . Even if they are equine cells, it is noteworthy to find that EBF exhibit a preference for fetal bovine serum factors over the horse serum factors, whereas the vice versa has been seen for neural cells . Merely, early studies have proposed that horse serum is appropriate for neuronal cell cultures [34, 35].
Moreover, despite the short passaging time and limited proliferation and population doubling rate, increased α-SMA expression was accompanied by higher protein amount in the presence of horse serum than in bovine serum, suggesting that HS might stimulate fibroblast differentiation into myofibroblasts. It is well known that myofibroblasts are able to produce large amount of extracellular matrix (ECM) proteins, as well as growth factors and cytokines and express cytoplasmic contractile structures including α-SMA. Thus, it seems that the horse serum increases the protein content in EBF by increasing synthesis of structural proteins, ECM and cytokines. Indeed, it is not yet known if differential expression of α-SMA and protein is functionally relevant.
Fetal bovine serum favors fibroblastic morphology with enhanced proliferation rate, population doubling, passage number and triggers cell differentiation (as vimentin staining showed), suggesting serum factors essential for the equine airway fibroblasts are available in the fetal bovine serum, whereas in the horse serum cells there were signs of degeneration or cell granularity. Moreover, we can conclude that serum withdrawal for 48 hours rather decrease EBF adaptation and enhance cell detachment than the 24 hour FBS depletion and in the latter case cell viability was though not altered, thus, EBF cultured in 10% FBS represent a good model allowing studying the response to drugs that influence cell proliferation and pathways of airway remodeling in airway diseases.
Study limitation: Animal serum is a complex mixture of a large number and variety of components; therefore, it is difficult to assess, at this stage, the significance of the observation that horse serum inhibits the programmed progress of equine airway cells through the lineage of differentiation in cultures.
Isolation and culture of equine bronchial fibroblasts
Primary equine bronchial fibroblasts were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 200 Units/ml Penicillin, 0.2 mg/ml Streptomycin, 5 mg/ml Amphotericin B (PAA Laboratories GmbH, Pasching, Austria). Surfaces of culture flask were not pretreated with adhesion supporting matrix like collagen.
Bronchial segment tissue samples were obtained from adult non-diseased slaughter horses of different breed, age and sex and slaughtered at local abattoirs (Freiberg, Germany). Primary equine bronchial fibroblasts (EBF) were isolated from these tissues. Briefly, the bronchial mucosa was removed from the bronchi, washed, minced to about 1-3 mm pieces, and 500 mg tissue were digested with 0.25% trypsin/EDTA (Sigma Aldrich, Deisehnhofen, Germany) in Hanks’ balanced salt solution (HBSS) (PAA Laboratories GmbH, Pasching, Austria) in 50-ml Erlenmeyer glass flasks and incubated at 37°C for 2 hours in humidified atmosphere of 5% CO2. Trypsinized samples were then filtered through sterile double-layered gauze and rinsed twice with ice-cold HBSS. Cell suspension was then further sieved through sterile nylon cell strainers (mesh size: 40 μm) (BD Biosciences, Franklin Lakes, NJ) and centrifuged two times to remove tissue debris.
To evaluate the effect of sera on proliferation and differentiation of primary equine bronchial fibroblasts, we used at least two to three different lots of cell culture appropriate not inactivated fetal bovine serum (FBS) (Gibco, Carlsbad, CA, USA) and horse serum (HS) (Sigma Aldrich, Deisehnhofen, Germany). Since it was not the objective of the study, we did not compare different serum products of several companies. FBS is routinely used to culture other cell lines in our laboratory, and should be tested before use; thus, after cell isolation, final cell pellets were first resuspended and cultured in DMEM containing 10% fetal bovine serum (FBS) for at least up to two passages. Thereafter, EBF were trypsinized and sub-cultured under different conditions: a) in DMEM without serum, or b) first in DMEM containing FBS and then serum deprived, or c) in DMEM in the presence of 10% FBS or d) in DMEM in the presence of 10% horse serum (HS). Cells were routinely passaged every 7 days with replacement of medium every 2 to 3 days. Unless and otherwise specified; cells were routinely cultured in 75 cm2 flasks (Greiner Bio-One, Frickenhausen, Germany).
Cryopreservation and thawing of EBF
Certain density of isolated primary EBF were either provided for direct culturing or frozen in 1 ml DMEM containing 20% FBS, 10% DMSO (Sigma Aldrich, Deisenhofen, Germany), penicillin, streptomycin and amphotericin B in liquid nitrogen until use. Also, some passages of EBF cultures were frozen. Cells were quickly thawed at 37°C in water bath and subsequently transferred into culture flasks with tempered culture medium (see above). Thawed cells were used for our study after 2 passages.
Cell viability, morphology and immunostaining
For cell counting and viability testing, cells were trypsinized and washed with PBS and stained with trypan blue dye (Sigma-Aldrich, Deisenhofen, Germany). Cells excluding the dye were counted using Neubauer cell chamber. Also, after 1-week of EBF culture in two conditions, i.e., DMEM + FBS or DMEM + HS, fibroblasts were trypsinized, centrifuged and an aliquot was re-suspended in PBS with trypan blue.
EBF were plated into 75 cm2 flasks at a density of 2 × 104 cells/cm2 and grown in 10 ml defined DMEM in the presence of 10% FBS or HS. Cell morphology was evaluated under inverted light microscope (Olympus CKX41). Digital images were taken from cells at different days and at possible confluence.
Expression of intermediate filaments in primary cultured EBF was evaluated using immunofluorescence staining against vimentin using a primary mouse monoclonal antibody and a secondary anti-mouse FITC-antibody (Dako Deutschland GmbH, Hamburg, Germany). EBF were cultured under the indicated culture conditions on glass cover slips (Carl Roth GmbH, Karlsruhe, Germany), washed twice with PBS after medium removal, and fixed in ice-cold acetone for 5 min at -20°C and immunostained as previously described .
Cell proliferation assay and population doubling time
To further assess the effects of sera types on cell proliferation and population doubling, EBF between passage 3 and 6 were transferred into 6-well plates (2 × 106 cells/cm2) and cell numbers were determined manually after day 1, 2, 3, 4, 6 and 8. Each time, the average from 2 wells was taken. The mean cell number was logarithmically transformed and the linear regression slope was calculated to derive the doubling time (DT). Proliferation rate was also determined in cryopreserved, thawed and cultured cells.
Furthermore, cell proliferation was measured by [3H]-thymidine incorporation assay . EBF (40 000 – 60 000 cells/well) were seeded into 12-well plates, in DMEM in the presence of 10% FBS, grown until 60% confluence, and further cultured in the presence of 10% FBS or serum-withdrawn for 24 or 48 hours. In all three settings, [3H]-thymidine (37 kBq/well) (Perkin Elmer, Waltham, MA) was added to the culture medium. 24 hours after incubation of cells with [3H]-thymidine, cells were washed in ice-cold PBS and incorporated radioactivity was determined by liquid scintillation counting (Beckman LS 6500 Scintillation Counter). Also, in thawed and cultured EBF, proliferation experiments were performed about 1-week after thawing, to avoid a major increase in the number of cumulative population doublings compared to experiments done with fresh cells.
Cell growth determination
To measure the effect of sera on cellular growth, total protein was measured at defined time points during culture in 6-well plates by the colorimetric method . In brief, EBF were rinsed twice in PBS and then trypsinized, centrifuged at 500 × g for 10 min. After removal of the supernatant, cell pellets were resuspended in PBS and sonicated 4 rounds for 30 second. Crude cell lysates were then diluted in 0.1 M potassium phosphate buffer (pH 7.4), incubated with copper in alkaline solution for 10 minutes at room temperature. After addition of Folin (Merck, Darmstadt, Germany), reduction of copper was completed within 45 minutes and quantitative analysis could be carried out by spectrophotometry at 660 nm (Beckman DU640 spectrophotometer, Beckman Coulter, Krefeld, Germany).
Primary EBF grown in 6-well plates under different culture conditions were harvested and suspended in sample buffer (containing 2% SDS, 25% [v/v] glycerol, 60 mM Tris–HCl and 0.1% bromphenol blue, 14.4 mM β-mercaptoethanol, pH 6.8) and boiled for 5 min. Equal amounts of whole cell lysate (2,5 × 105 cells/ml) were subjected to SDS-PAGE; samples were separated on 12% acrylamide gel under reducing conditions and transferred to a nitrocellulose membrane (Whatman GmbH, Dassel, Germany). The membrane was then blocked in 3% BSA (PAA Laboratories) with TBST (20 mM Tris–HCl, pH 7.5, 150 mM NaCl and 0.05% [v/v] Tween-20) for 1 h at room temperature. α-SMA was detected following an overnight incubation of samples with mouse monoclonal antibody against human anti-α-SMA (1:1000; Sigma-Aldrich) and β-actin was detected using mouse monoclonal antibody against human anti-β-actin (1:10,000; Sigma-Aldrich) in 3% BSA-TBST at 4°C. Band visualisation was performed using alkaline phosphatase conjugated secondary anti-mouse igG antibody (1:5000; Promega GmbH, Mannheim, Germany) over 1 h at room temperature. Enzyme activity was detected using Western Blue stabilised substrate for alkaline phosphate (Promega). The membranes were digitalized and quantitated by densitometry analysis (SynGene, Cambridge, UK).
Data and statistical analysis
All data are expressed as means ± SEM. Statistical significance of differences was evaluated by paired two-tailed student’s t-test using GraphPad Prism version 5.1 (GraphPad Software, San Diego, CA, USA). P < 0.05 was considered significant.
This work was supported financially by Frankenförder Forschungsgesellschaft mbH (Berlin, Germany). We thank the abattoirs of Freiberg and Jena for access to fresh bronchial tissue samples. We also thank Martina Wieczorek for technical assistance.
- Jeffery PK: Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med. 2001, 164: S28-S38. 10.1164/ajrccm.164.supplement_2.2106061.View ArticlePubMedGoogle Scholar
- An SS, Bai TR, Bates JH, Black JL, Brown RH, Brusasco V, Chitano P, Deng L, Dowell M, Eidelman DH, Fabry B, Fairbank NJ, Ford LE, Fredberg JJ, Gerthoffer WT, Gilbert SH, Gosens R, Gunst SJ, Halayko AJ, Ingram RH, Irvin CG, James AL, Janssen LJ, King GG, Knight DA, Lauzon AM, Lakser OJ, Ludwig MS, Lutchen KR, Maksym GN, et al: Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J. 2007, 29: 834-860. 10.1183/09031936.00112606.PubMed CentralView ArticlePubMedGoogle Scholar
- Yamauchi K, Inoue H: Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling. Allergol Int. 2007, 56: 321-329. 10.2332/allergolint.R-07-151.View ArticlePubMedGoogle Scholar
- Fernandes DJ, Bonacci JV, Stewart AG: Extracellular matrix, integrins, and mesenchymal cell function in the airways. Curr Drug Targets. 2006, 7: 567-577. 10.2174/138945006776818700.View ArticlePubMedGoogle Scholar
- Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR: Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol. 1990, 3: 507-511. 10.1165/ajrcmb/3.5.507.View ArticlePubMedGoogle Scholar
- Ichikawa T, Sugiura H, Koarai A, Yanagisawa S, Kanda M, Hayata A, Furukawa K, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M: Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am J Physiol Lung Cell Mol Physiol. 2008, 295: L800-L808. 10.1152/ajplung.90264.2008.View ArticlePubMedGoogle Scholar
- Kolodsick JE, Peters-Golden M, Larios J, Toews GB, Thannickal VJ, Moore BB: Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am J Respir Cell Mol Biol. 2003, 29: 537-544. 10.1165/rcmb.2002-0243OC.View ArticlePubMedGoogle Scholar
- Haag S, Matthiesen S, Juergens UR, Racké K: Muscarinic receptors mediate stimulation of collagen synthesis in human lung fibroblasts. Eur Respir J. 2008, 32: 555-562. 10.1183/09031936.00129307.View ArticlePubMedGoogle Scholar
- Liu X, Ostrom RS, Insel PA: cAMP-elevating agents and adenylyl cyclase overexpression promote an antifibrotic phenotype in pulmonary fibroblasts. Am Physiol Cell Physiol. 2004, 286: C1089-C1099.View ArticleGoogle Scholar
- Silvestri M, Fregonese L, Sabatini F, Dasic G, Rossi GA: Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J. 2001, 18: 139-145. 10.1183/09031936.01.00067901.View ArticlePubMedGoogle Scholar
- Matthiesen S, Bahulayan A, Kempkens S, Haag S, Fuhrmann M, Stichnote C, Juergens UR, Racké K: Muscarinic receptors mediate stimulation of human lung fibroblast proliferation. Am J Respir Cell Mol Biol. 2006, 35: 621-627. 10.1165/rcmb.2005-0343RC.View ArticlePubMedGoogle Scholar
- Jacques E, Semlali A, Boulet LP, Chakir J: AP-1 overexpression impairs corticosteroid inhibition of collagen production by fibroblasts isolated from asthmatic subjects. Am J Physiol Lung Cell Mol Physiol. 2010, 299: L281-L287. 10.1152/ajplung.00360.2009.View ArticlePubMedGoogle Scholar
- Sugiura H, Liu X, Duan F, Kawasaki S, Togo S, Kamio K, Wang XQ, Mao L, Ahn Y, Ertl RF, Bargar TW, Berro A, Casale TB, Rennard SI: Cultured lung fibroblasts from ovalbumin-challenged "asthmatic" mice differ functionally from normal. Am J Respir Cell Mol Biol. 2007, 37: 424-430. 10.1165/rcmb.2007-0089OC.PubMed CentralView ArticlePubMedGoogle Scholar
- Warnken M, Haag S, Matthiesen S, Juergens UR, Racke K: Species differences in expression pattern of arginase isoenzymes and differential effects of arginase inhibition on collagen synthesis in human and rat pulmonary fibroblasts. Naunyn Schmied Arch Pharmacol. 2010, 381: 297-304. 10.1007/s00210-009-0489-6.View ArticleGoogle Scholar
- Bettger WJ, McKeehan WL: Mechanisms of cellular nutrition. Physiol Rev. 1986, 66: 1-35.PubMedGoogle Scholar
- Kumar RK, O'Grady R, Li W, Smith LW, Rhodes GC: Primary culture of adult mouse lung fibroblasts in serum-free medium: responses to growth factors. Exp Cell Res. 1991, 193: 398-404. 10.1016/0014-4827(91)90112-8.View ArticlePubMedGoogle Scholar
- Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO: The transcriptional program in the response of human fibroblasts to serum. Science. 1999, 283: 83-87. 10.1126/science.283.5398.83.View ArticlePubMedGoogle Scholar
- Leicht M, Marx G, Karbach D, Gekle M, Köhler T, Zimmer HG: Mechanism of cell death of rat cardiac fibroblasts induced by serum depletion. Mol Cell Biochem. 2003, 251: 119-126. 10.1023/A:1025446302759.View ArticlePubMedGoogle Scholar
- Simm A, Bertsch G, Frank H, Zimmermann U, Hoppe J: Cell death of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis. J Cell Sci. 1997, 110: 819-828.PubMedGoogle Scholar
- Minotti S, Scicchitano BM, Nervi C, Scarpa S, Lucarelli M, Molinaro M, Adamo S: Vasopressin and insulin-like growth factors synergistically induce myogenesis in serum-free medium. Cell Growth Differ. 1998, 9: 155-163.PubMedGoogle Scholar
- Goto S, Miyazaki K, Funabiki T, Yasumitsu H: Serum-free culture conditions for analysis of secretory proteinases during myogenic differentiation of mouse C2C12 myoblasts. Anal Biochem. 1999, 272: 135-142. 10.1006/abio.1999.4163.View ArticlePubMedGoogle Scholar
- Barnes D, Sato G: Serum-free cell culture: a unifying approach. Cell. 1980, 22: 649-655. 10.1016/0092-8674(80)90540-1.View ArticlePubMedGoogle Scholar
- Agata H, Watanabe N, Ishii Y, Kubo N, Ohshima S, Yamazaki M, Tojo A, Kagami H: Feasibility and efficacy of bone tissue engineering using human bone marrow stromal cells cultivated in serum-free conditions. Biochem Biophys Res Commun. 2009, 382: 353-358. 10.1016/j.bbrc.2009.03.023.View ArticlePubMedGoogle Scholar
- Chase LG, Lakshmipathy U, Solchaga LA, Rao MS, Vemuri MC: A novel serum-free medium for the expansion of human mesenchymal stem cells. Stem Cell Res Ther. 2010, 1: 8-10.1186/scrt8.PubMed CentralView ArticlePubMedGoogle Scholar
- Shibeshi W, Abraham G, Kneuer C, Ellenberger C, Seeger J, Schoon HA, Ungemach FR: Isolation and culture of primary equine tracheal epithelial cells. In Vitro Cell Dev Biol Anim. 2008, 44: 179-184. 10.1007/s11626-008-9099-8.View ArticlePubMedGoogle Scholar
- Gruenert DC, Finkbeiner WE, Widdicombe JH: Culture and transformation of human airway epithelial cells. Am J Physiol. 1995, 268: L347-L360.PubMedGoogle Scholar
- Honn KV, Singley JA, Chavin W: Fetal bovine serum: a multivariate standard. Proc Soc Exp Biol Med. 1975, 149: 344-347. 10.3181/00379727-149-38804.View ArticlePubMedGoogle Scholar
- Gos M, Miloszewska J, Swoboda P, Trembacz H, Skierski J, Janik P: Cellular quiescence induced by contact inhibition or serum withdrawal in C3H10T1/2 cells. Cell Prolif. 2005, 38: 107-116. 10.1111/j.1365-2184.2005.00334.x.View ArticlePubMedGoogle Scholar
- Hetzel M, Bachem M, Anders D, Trischler G, Faehling M: Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung. 2005, 183: 225-237. 10.1007/s00408-004-2534-z.View ArticlePubMedGoogle Scholar
- Chen M, Huang J, Yang X, Liu B, Zhang W, Huang L, Deng F, Ma J, Bai Y, Lu R, Huang B, Gao Q, Zhuo Y, Ge J: Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One. 2012, 7: e28203-10.1371/journal.pone.0028203.PubMed CentralView ArticlePubMedGoogle Scholar
- Fernyhough ME, Hausman GJ, Dodson MV: () Progeny from dedifferentiated bovine adipocytes display protracted adipogenesis. Cells Tissues Organs (Print). 2008, 188: 359-372. 10.1159/000134007.View ArticleGoogle Scholar
- Wu H, Ren Y, Li S, Wang W, Yuan J, Guo X, Liu D, Cang M: In vitro culture and induced differentiation of sheep skeletal muscle satellite cells. Cell Biol Int. 2012, 36: 579-587. 10.1042/CBI20110487.View ArticlePubMedGoogle Scholar
- Ahmed YA, Tatarczuch L, Pagel CN, Davies HM, Mirams M, Mackie EJ: Hypertrophy and physiological death of equine chondrocytes in vitro. Equine Vet J. 2007, 39: 546-552. 10.2746/042516407X223699.View ArticlePubMedGoogle Scholar
- Fedoroff S, Hall C: Effect of horse serum on neural cell differentiation in tissue culture. In Vitro. 1979, 15: 641-648. 10.1007/BF02623400.View ArticlePubMedGoogle Scholar
- Moonen G, Nelson PG: Some physiological properties of astrocytes in primary cultures. Dynamic Properties of Glial Cells. Edited by: Schoffeniels E, Franck G, Hertz L, Towers DB. New York: Pergamon Press; 1978:389-393.Google Scholar
- Abraham G, Zizzadoro C, Kacza J, Ellenberger C, Abs V, Franke J, Schoon HA, Seeger J, Tesfaigzi Y, Ungemach FR: Growth and differentiation of primary and passaged equine bronchial epithelial cells under conventional and air-liquid-interface culture conditions. BMC Vet Res. 2011, 7: 26-10.1186/1746-6148-7-26.PubMed CentralView ArticlePubMedGoogle Scholar
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem. 1951, 193: 265-275.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.